Evolution Group Company News

Epic Code:
Sub Sector:
Market Cap:

General Financial
Investment Services
UK Main Market
335.59145484 GBPm

Data as of 10:00 23/09/2009. Check director details and other company announcments at Evolution Group Website .

RNS News for Evolution Group

Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.

Latest Evolution Group News

Evgen Pharma PLC (EVG.L) Moves 1.18%
Melville Review - 19 hours ago
Shares of Evgen Pharma PLC (EVG.L) are moving on volatility today 1.18% or 0.20 from the open. The LSE listed company saw a recent bid of 17.20 and 132214 shares have traded hands in the session.

07/25/2017 10:45 AM

Market Risers: Elegant Hotels Group PLC, Evgen Pharma PLC, Fresnillo Plc
DirectorsTalk Interviews - Jul 17, 2017
Shares in Evgen Pharma PLC company symbol: LON:EVG has increased 5% or 0.9 points throughout today's trading session so far.

07/17/2017 12:48 PM

Evgen Pharma Plc Making clinical progress
DirectorsTalk Interviews - Jun 21, 2017
Hardman & Co Report Report Downloads Evgen Pharma Plc (LON:EVG) is a virtual pharmaceutical company focused on the development of a synthetic version of a natural product, sulforaphane, which is known to modulate key signalling pathways involved ...

06/21/2017 07:33 AM

Market Risers: Evgen Pharma PLC, Fresnillo Plc, Hammerson plc, Lionsgold Ltd
DirectorsTalk Interviews - Jun 14, 2017
Shares in Evgen Pharma PLC with ticker code: LON:EVG has gained 5.66% or 0.99 points during today's session so far. Buyers have remained optimistic during this period.

06/14/2017 01:08 PM

Evgen Pharma Plc Investor Presentation Year End Mar 31 2017
DirectorsTalk Interviews - Jun 14, 2017
Evgen Pharma Plc is a clinical stage drug development company whose lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke.

06/14/2017 01:00 PM

Evgen Pharma shares jump after positive updates on two Phase II clinical ...
Proactive Investors UK - Jun 1, 2017
Evgen Pharma PLC (LON:EVG) saw its shares jump almost 12% higher this morning after the drug development company reported positive updates on two Phase II clinical trials for its SFX-01 treatment with “no safety or tolerance issues reported to date”.

06/01/2017 10:43 AM